Tyramine hydrochloride

CAS No. 60-19-5

Tyramine hydrochloride( —— )

Catalog No. M21102 CAS No. 60-19-5

Tyramine hydrochloride is a biogenic trace amine that is generated via the decarboxylation of the amino acid tyrosine exhibiting neuromodulatory properties as well as cardiovascular and immunological effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 37 In Stock
1G 45 In Stock

Biological Information

  • Product Name
    Tyramine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Tyramine hydrochloride is a biogenic trace amine that is generated via the decarboxylation of the amino acid tyrosine exhibiting neuromodulatory properties as well as cardiovascular and immunological effects.
  • Description
    Tyramine hydrochloride is a biogenic trace amine that is generated via the decarboxylation of the amino acid tyrosine exhibiting neuromodulatory properties as well as cardiovascular and immunological effects.
  • In Vitro
    Tyramine is normally broken down in your body by an enzyme called MAO (monoamine oxidase).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    60-19-5
  • Formula Weight
    173.64
  • Molecular Formula
    C8H12ClNO
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (575.90 mM)
  • SMILES
    Cl.NCCc1ccc(O)cc1
  • Chemical Name
    4-Hydroxyphenethylammonium chloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gaby Andersen Patrick et al. Food sources and biomolecular targets of tyramine.[J]. Nutrition Reviews 2018.
molnova catalog
related products
  • Penetratin-Arg

    Penetratin-Arg

  • Brentuximab vedotin

    Brentuximab vedotin (SGN-35) is a CD30-targeting antibody-active molecule conjugate (ADC) that combines a CD30 monoclonal antibody with the microtubule disrupting agent monomethylauristatin E for the study of lymphoma.

  • TN-16

    TN-16 is a microtubule polymerization inhibitor?(IC50 :0.4-1.7 μM).